logo
advertisement
   Login        
    Register        
   Search       
    Submit to CRTER
   Submit to NRR  

Autologous bone marrow mesenchymal stem cells transplantation for the treatment of severe diabetic foot in one

Publisher:liyzbs  Publish Time:Monday, August 09, 2010 
Source:crter

Chen Ling-zhen, Chen Jia-yu, Wu Jin-ming, Yu Wei, Zhan Yu

Abstract
BACKGROUND: Previous studies have shown that bone marrow mesenchymal stem cells (BMSCs) can differentiate into vascular endothelial cells, and then further differentiate into new blood capillary, resulting in forming new collateral branch and in improving blood supply in local site, which can provide new ideas for treatment of ischemic lower extremity disorders.
OBJECTIVE: To observe clinical effects of autologous BMSCs transplantation on the treatment of severe diabetic foot.
METHODS: One patient with type 2 diabetes and severe diabetic foot ulcers was included in this research. BMSCs were isolated and expanded from 50 mL bone marrow aspirates through lower-extremity artery CT vascular reconstruction, which suggested lower-extremity angiosclerosis, stenosis and occlusion. Mononuclear cells were harvested by density gradient centrifugation, and BMSCs were isolated and purified using adherent culture method, and then infused into patients via intravenous infusion following microbiological detection. At 3 and 6 months, 7 and 30 days following transplantation, clinical symptoms such as pain, cold sensation, intermittent claudication, ankle-brachial index (ABI), ulcer area and gangrene were observed. Improvement and blood flow in the lower extremity and artery lateral branch reconstruction were measured by color Doppler flow imaging and CT scan.
RESULTS AND CONCLUSION: At 3 months following transplantation, pain and cold sensation significantly relieved and numbness was improved. At 6 months after transplantation, pain relief was achieved, ABI significantly increased, foot ulcers healed completely, lower extremity was maintained, and foot function in walking was well preserved. New vessels formation was visible and blood flow was significantly improved by color Doppler flow imaging and CT scan. No heart/live/lung/kidney function injury was observed during the transplantation. The patient was followed up for 14 months, no transplantation-related complications were observed. Autologous BMSCs transplantation provides a new way for the therapy of diabetic foot.

Full Text:Click

 

Print』『Close

      

All rights reserved    
Publishing House of Journal of Clinical Rehabilitation Tissue Engineering Research 
Publishing House of Neural Regeneration Research
CRTER website group Liao ICP 05011357

CRTER   Address:p.o.box  1200, shenyang  110004   Tel:024-23384352  Fax:024-23388105   Submission:
http://oa.crter.org/zglckfen/ch/index.aspx
NRR       Address:p.o.box  1234, shenyang  110004   Tel:024-23394178  Fax:024-23394178   Submission:
http://oa.crter.org/nrren/ch/index.aspx